Strata Critical Medical Inc
SRTA
78 hedge funds and large institutions have $275M invested in Strata Critical Medical Inc in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 20 closing their positions.
26% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 19
22% more call options, than puts
Call options by funds: $7.04M | Put options by funds: $5.78M
5% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 20
1% less funds holding
Funds holding: 79 → 78 (-1)
4.44% less ownership
Funds ownership: 50.6% → 46.16% (-4.4%)
13% less capital invested
Capital invested by funds: $316M → $275M (-$40.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$4.27M |
| 2 |
NAMA
Nikko Asset Management Americas
New York
|
+$3.82M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$3.06M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.12M |
| 5 |
EMG
ETF Managers Group
Summit,
New Jersey
|
+$1.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$38.3M |
| 2 |
AIM
Allen Investment Management
New York
|
-$2.93M |
| 3 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$2.54M |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.69M |
| 5 |
IP
Intellectus Partners
San Francisco,
California
|
-$1.54M |
SRTA Hedge Fund Activity: Q1 2022 in Review
78 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc (SRTA) for Q1 2022, worth a combined $275M — down 13% from $316M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of SRTA and 19 opened new positions — a net loss of 1 holder — while 19 trimmed existing stakes and 24 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $4.27M. The largest seller was Sumitomo Mitsui Trust Group, exiting entirely with an estimated $38.3M sold.
- 78 institutional investors held Strata Critical Medical Inc (SRTA) as of Q1 2022, down from 79 in Q4 2021.
- Funds reported $275M of Strata Critical Medical Inc stock for Q1 2022, down 13% quarter-over-quarter.
- 19 funds opened new Strata Critical Medical Inc positions in Q1 2022 and 20 closed out, a net change of -1 holder.
- The largest Strata Critical Medical Inc buyer in Q1 2022 was Millennium Management, an estimated $4.27M added.
- The largest Strata Critical Medical Inc seller in Q1 2022 was Sumitomo Mitsui Trust Group, an estimated $38.3M sold.
Based on aggregated 13F filings for Q1 2022.